Kolexia
Martin-Blondel Guillaume Maladies infectieuses
Martin-Blondel Guillaume
Maladies infectieuses
Hôpital Purpan
Toulouse, France
246 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Infections à VIH Leucoencéphalopathie multifocale progressive Leucoencéphalopathies Syndrome inflammatoire de restauration immunitaire Syndrome respiratoire aigu sévère Tuberculose Pneumopathie infectieuse Leishmaniose

Collaborateurs

Voir plus
Delobel Pierre
Delobel Pierre
Hôpital Purpan, Toulouse, France
Marchou Bruno
Marchou Bruno
Centre Hospitalier de Tulle, Tulle, France
Izopet Jacques
Izopet Jacques
Hôpital Purpan, Toulouse, France
Liblau Roland
Liblau Roland
Hôpital Purpan, Toulouse, France

Industries

Voir plus
MSD
19 collaboration(s)
Dernière en 2023
Adliva
16 collaboration(s)
Dernière en 2021
Pfizer
11 collaboration(s)
Dernière en 2023
Sanofi
5 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study on the behalf of G2I and IFM.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   01 mars 2024
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of infection   16 février 2024
SPLEEN: Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients
Essai Clinique (CHU Poitiers)   30 janvier 2024
Brain abscess caused by Listeria monocytogenes and Toxoplasma gondii.
The Lancet. Infectious diseases   29 janvier 2024
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
HemaSphere   27 janvier 2024
Intact proviruses are enriched in the colon and associated with PD-1 TIGIT mucosal CD4 T cells of people with HIV-1 on antiretroviral therapy.
EBioMedicine   30 décembre 2023
Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies.
The Journal of infectious diseases   23 novembre 2023
Cumulative Incidence and Characteristics of Infections Requiring Treatment, Delay in Treatment Administration or Hospitalisation in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti BCMA or Anti GPRC5D Bispecific Antibodies
65th ASH Annual Meeting Abstracts   02 novembre 2023
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients.
Med (New York, N.Y.)   01 novembre 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ medicine   27 octobre 2023